Business Description
Redcare Pharmacy NV
ISIN : NL0012044747
Total Employee Number:
2,648Compare
Compare
Traded in other countries / regions
RDC.Germany0RJT.UKSAEYY.USASHOP.Austria1RDC.ItalyRDC.Switzerland IPO Date
2020-10-09Description
Redcare Pharmacy NV is an online pharmacy business for prescription and nonprescription (over-the-counter) pharmaceuticals, beauty and personal care products (BPC) and food supplements. Besides OTC, nutritional supplements, beauty and personal care products as well as an extensive assortment of health-related products in all markets, the company also provides prescription drugs for customers in Germany, Switzerland and the Netherlands. It operates in two segments, namely DACH segment that includes sales in Germany, Austria and Switzerland; and the International segment that includes sales across Belgium, the Netherlands, France and Italy. The DACH segment accounts for the majority of the revenue.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.38 | |||||
Equity-to-Asset | 0.38 | |||||
Debt-to-Equity | 0.79 | |||||
Debt-to-EBITDA | 7.58 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 3.9 | |||||
Beneish M-Score | -2.41 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 29.7 | |||||
3-Year EPS without NRI Growth Rate | 23.5 | |||||
3-Year FCF Growth Rate | 1.8 | |||||
3-Year Book Growth Rate | 5.4 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 12.59 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 100 | |||||
9-Day RSI | 99.96 | |||||
14-Day RSI | 99.14 | |||||
6-1 Month Momentum % | -39.76 | |||||
12-1 Month Momentum % | -69.52 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.54 | |||||
Quick Ratio | 0.97 | |||||
Cash Ratio | 0.36 | |||||
Days Inventory | 28.09 | |||||
Days Sales Outstanding | 15.31 | |||||
Days Payable | 36.96 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.4 | |||||
Shareholder Yield % | -10.47 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 21.93 | |||||
Operating Margin % | -0.78 | |||||
Net Margin % | -1.22 | |||||
EBITDA Margin % | 1.52 | |||||
FCF Margin % | -3.35 | |||||
OCF Margin % | 0.52 | |||||
ROE % | -7.81 | |||||
ROA % | -3.18 | |||||
ROIC % | -2.89 | |||||
3-Year ROIIC % | 14.65 | |||||
ROC (Joel Greenblatt) % | -9.74 | |||||
ROCE % | -2.82 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 395.11 | |||||
PS Ratio | 0.44 | |||||
PB Ratio | 3.01 | |||||
Price-to-Tangible-Book | 22.42 | |||||
Price-to-Operating-Cash-Flow | 81.14 | |||||
EV-to-EBIT | -69.84 | |||||
EV-to-Forward-EBIT | 118.6 | |||||
EV-to-EBITDA | 34.03 | |||||
EV-to-Forward-EBITDA | 185.87 | |||||
EV-to-Revenue | 0.52 | |||||
EV-to-Forward-Revenue | 1.02 | |||||
EV-to-FCF | -15.58 | |||||
Price-to-GF-Value | 0.36 | |||||
Price-to-Median-PS-Value | 0.33 | |||||
Earnings Yield (Greenblatt) % | -1.43 | |||||
FCF Yield % | -7.55 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:SHPPF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Redcare Pharmacy NV Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 3,575.353 | ||
| EPS (TTM) ($) | -2.179 | ||
| Beta | 1.6961 | ||
| 3-Year Sharpe Ratio | 0.28 | ||
| 3-Year Sortino Ratio | 1.04 | ||
| Volatility % | 53.85 | ||
| 14-Day RSI | 99.14 | ||
| 14-Day ATR ($) | 0.976288 | ||
| 20-Day SMA ($) | 51.066 | ||
| 12-1 Month Momentum % | -69.52 | ||
| 52-Week Range ($) | 45.18 - 148.22 | ||
| Shares Outstanding (Mil) | 20.11 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Redcare Pharmacy NV Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Redcare Pharmacy NV Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Redcare Pharmacy NV Frequently Asked Questions
What is Redcare Pharmacy NV(SHPPF)'s stock price today?
The current price of SHPPF is $64.80. The 52 week high of SHPPF is $148.22 and 52 week low is $45.18.
When is next earnings date of Redcare Pharmacy NV(SHPPF)?
The next earnings date of Redcare Pharmacy NV(SHPPF) is .
Does Redcare Pharmacy NV(SHPPF) pay dividends? If so, how much?
Redcare Pharmacy NV(SHPPF) does not pay dividend.
Guru Commentaries on OTCPK:SHPPF
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Redcare Pharmacy NV
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers